Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
BMC Pulm Med ; 20(1): 231, 2020 Aug 31.
Article in English | MEDLINE | ID: mdl-32867748

ABSTRACT

BACKGROUND: Multidetector computed tomography (MDCT) angiography is a useful examination to detect the source of the bleeding in patients with hemoptysis. The aim of the study was to prospectively evaluate the role and clinical efficacy of MDCT angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence. METHODS: It is a double-center study which included 57 hemoptysis patients undergoing MDCT angiography prior to BAE from August 2019 to July 2020. A prospective analysis of culprit arteries detected by MDCT angiography allowed an evaluation of the role of this technique. A follow-up was done to assess the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis. RESULTS: The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 ± 1.73. Among which, the average numbers of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 ± 0.41 and 1.04 ± 1.57, respectively. The immediate clinical success rate, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7, 18.5, 16.7%, respectively. Aspergilloma (HR = 6.63, 95% CI: 1.31-33.60, p = 0.022) was associated with an increase in the risk of early recurrence. CONCLUSIONS: MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.


Subject(s)
Bronchial Arteries/abnormalities , Computed Tomography Angiography/methods , Hemoptysis/therapy , Multidetector Computed Tomography/methods , Tuberculosis, Pulmonary/complications , Adult , Aged , Bronchi/diagnostic imaging , Bronchial Arteries/diagnostic imaging , Computed Tomography Angiography/mortality , Embolization, Therapeutic/methods , Female , Hemoptysis/mortality , Humans , Male , Middle Aged , Multidetector Computed Tomography/mortality , Proportional Hazards Models , Prospective Studies , Recurrence , Survival Rate , Treatment Outcome
2.
Eur Radiol ; 29(4): 1950-1958, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30324381

ABSTRACT

OBJECTIVES: To compare the average number of culprit arteries per patient, clinical success rate, and hemoptysis-free survival rate between hemoptysis patients with multidetector computed tomography (MDCT) angiography prior to bronchial artery embolization (BAE) and those without preprocedural MDCT angiography METHODS: This retrospective study was approved by the institutional review board with waiver of patient informed consent. From September 2012 to March 2017, 157 consecutive hemoptysis patients had been undergoing BAE. Among them, 106 patients received preprocedural MDCT angiography (MDCT group), while 51 patients did not receive preprocedural MDCT angiography (control group). The average number of culprit arteries per patient, clinical success rate, and hemoptysis-free survival rate were compared between the two groups. RESULTS: The average number of culprit ectopic bronchial arteries and that of non-bronchial systemic arteries originating from the subclavian and internal mammary arteries per patient in the MDCT group were both significantly higher than those in the control group (0.15 ± 0.51 vs 0.04 ± 0.20, p = 0.022, and 0.17 ± 0.56 vs 0.08 ± 0.39, p = 0.040, respectively). The clinical success rate of BAE with preprocedural MDCT angiography tended to be higher than that without MDCT angiography (97.2 vs 88.2%, p = 0.057). Importantly, patients in the MDCT group had a significantly higher hemoptysis-free early survival rate compared to those in the control group (96.1 vs 86.7%, p = 0.031). CONCLUSIONS: Preprocedural MDCT angiography helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries during BAE, and can improve the hemoptysis-free early survival rate, which could be recommended as a regular examination prior to BAE in patients with hemoptysis. KEY POINTS: • Preprocedural MDCT angiography helps detect culprit ectopic bronchial arteries and NBSAs originating from subclavian and internal mammary arteries during BAE. • Conducting MDCT angiography prior to BAE can improve hemoptysis-free early survival rate in hemoptysis patients.


Subject(s)
Bronchial Arteries/abnormalities , Embolization, Therapeutic/methods , Hemoptysis/therapy , Adult , Aged , Bronchi/diagnostic imaging , Bronchial Arteries/diagnostic imaging , Computed Tomography Angiography/methods , Computed Tomography Angiography/mortality , Disease-Free Survival , Female , Hemoptysis/mortality , Humans , Male , Mammary Arteries/abnormalities , Mammary Arteries/diagnostic imaging , Middle Aged , Multidetector Computed Tomography/methods , Multidetector Computed Tomography/mortality , Retrospective Studies , Secondary Prevention , Subclavian Artery/abnormalities , Subclavian Artery/diagnostic imaging , Survival Rate , Treatment Outcome
3.
Int J Cardiol ; 266: 56-60, 2018 Sep 01.
Article in English | MEDLINE | ID: mdl-29887473

ABSTRACT

PURPOSE: Aortic stenosis (AS) in bicuspid aortic valve (BAV) remains a challenge for transcatheter aortic valve implantation (TAVI). BAV is a condition encountered in young adults as well as elderly patients. Frequently we face in clinical practice elderly patients with BAV and severe AS, but there is little evidence concerning TAVI in this population. The aim of our study was to compare anatomic features and outcomes of bicuspid and tricuspid patients with AS undergoing TAVI. METHODS: 83 consecutive BAV patients undergoing TAVI were matched, in a 1:2 ratio, to 166 tricuspid patients. Multi-detector computed tomography (MDCT) and transthoracic echocardiogram (TTE) were assessed at baseline. Primary endpoint was all-cause mortality and early safety at 30 days according to Valve Academic Research Consortium criteria 2 (VARC-2). Secondary endpoint included device success. RESULTS: BAV patients presented more aortic root calcifications, smaller diameter of left ventricular outflow tract (LVOT) and dilated aorta. We did not observe any statistically significant difference concerning all-cause mortality and early safety at 30 days. However higher intra-procedural TAV-in-TAV bailout procedure was observed in the BAV cohort, with consequent reduction of device success rate. CONCLUSIONS: Patients with BAV present more complex anatomy at baseline as compared to tricuspid AS patients. These anatomical features lead to more frequent TAV-in-TAV bailout procedure and lower device success rate, but are not associated with higher mortality rate at 30 days. Our findings support the feasibility of TAVI in BAV, but larger studies with longer follow-up and a focus on sizing are required.


Subject(s)
Aortic Valve/abnormalities , Aortic Valve/anatomy & histology , Aortic Valve/diagnostic imaging , Heart Valve Diseases/diagnostic imaging , Transcatheter Aortic Valve Replacement/mortality , Transcatheter Aortic Valve Replacement/trends , Aged , Aged, 80 and over , Bicuspid Aortic Valve Disease , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Mortality/trends , Multidetector Computed Tomography/mortality , Multidetector Computed Tomography/trends , Treatment Outcome
4.
Eur Radiol ; 27(6): 2563-2569, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27752833

ABSTRACT

OBJECTIVES: To determine whether washout characteristics of dynamic contrast-enhanced computed tomography (CT) could predict survival in patients with extrahepatic cholangiocarcinoma (EHC). METHODS: This study collected 46 resected cases. All cases were examined by dynamic contrast study on multidetector-row CT. Region-of-interest measurements were obtained at the non-enhanced, portal venous phase and delayed phase in the tumour and were used to calculate the washout ratio as follows: [(attenuation value at portal venous phase CT - attenuation value at delayed enhanced CT)/(attenuation value at portal venous phase CT - attenuation value at unenhanced CT)] × 100. On the basis of the median washout ratio, we classified the cases into two groups, a high-washout group and low-washout group. Associations between overall survival and various factors including washout rates were analysed. RESULTS: The median washout ratio was 29.4 %. Univariate analysis revealed that a lower washout ratio, venous invasion, lymphatic permeation and lymph node metastasis were associated with shorter survival. Multivariate analysis identified the lower washout ratio as an independent prognostic factor (hazard ratio, 3.768; p value, 0.027). CONCLUSIONS: The washout ratio obtained from the contrast-enhanced CT may be a useful imaging biomarker for the prediction of survival of patients with EHC. KEY POINTS: • Dynamic contrast study can evaluate the aggressiveness of extrahepatic cholangiocarcinoma. • A lower washout ratio was an independent prognostic factor for overall survival. • CT can predict survival and inform decisions on surgical options or chemotherapy.


Subject(s)
Bile Duct Neoplasms/diagnostic imaging , Cholangiocarcinoma/diagnostic imaging , Adult , Aged , Aged, 80 and over , Bile Duct Neoplasms/mortality , Bile Duct Neoplasms/surgery , Cholangiocarcinoma/mortality , Cholangiocarcinoma/surgery , Contrast Media , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Multidetector Computed Tomography/methods , Multidetector Computed Tomography/mortality , Multimodal Imaging/methods , Multimodal Imaging/mortality , Portal Vein/diagnostic imaging , Prognosis , Proportional Hazards Models , Retrospective Studies , Tomography, Spiral Computed/methods , Tomography, Spiral Computed/mortality
5.
Radiology ; 281(3): 816-825, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27438167

ABSTRACT

Purpose To test the hypothesis that patients with pancreatic adenocarcinoma who otherwise are viewed to have resectable disease but have preoperative findings of extrapancreatic perineural invasion (EPNI) and/or duodenal invasion at multidetector computed tomography (CT) have reduced postoperative survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). Materials and Methods This study was approved by the institutional review board and complied with HIPAA. The authors retrospectively evaluated 76 consecutive patients with PDAC who underwent preoperative multidetector CT and subsequent pancreaticoduodenectomy. Two radiologists blinded to surgical pathology results and clinical outcome evaluated multidetector CT images for evidence of EPNI and duodenal invasion; discrepancies were resolved by consensus. Also determined for each patient were resected lymph node status, tumor size, surgical margin status, time to progression, and time to death. Data were assessed with the Goodman-Kruskal gamma for correlations among indicators and the log-rank test, Kaplan-Meier estimates, and multivariate Cox proportional hazards regression for survival analysis. Results In univariate analysis, duodenal invasion and/or EPNI on preoperativemultidetector CT images was associated with significantly decreased progression-free survival (P < .0001) and overall survival (P = .0013), and the clinical indicators (lymph node status, tumor size, and surgical margin status) as well as duodenal invasion and/or EPNI showed correlation with each other. In multivariate regression that included multidetector CT findings as well as the three traditional clinical indicators, only duodenal invasion and/or EPNI showed significant independent association with reduction in both modes of survival (P < .0001 and P = .014, respectively). Interobserver agreement was substantial with respect to EPNI and duodenal invasion (κ = 0.691 and 0.682, respectively). Conclusion Patients with evidence of EPNI and/or duodenal invasion on preoperative multidetector CT images have significantly reduced survival after pancreaticoduodenectomy for PDAC. © RSNA, 2016.


Subject(s)
Carcinoma, Pancreatic Ductal/pathology , Duodenal Neoplasms/pathology , Pancreatic Neoplasms/pathology , Pancreaticoduodenectomy/methods , Peripheral Nervous System Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Pancreatic Ductal/mortality , Carcinoma, Pancreatic Ductal/surgery , Disease-Free Survival , Duodenal Neoplasms/mortality , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multidetector Computed Tomography/methods , Multidetector Computed Tomography/mortality , Neoplasm Invasiveness , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy/mortality , Peripheral Nervous System Neoplasms/mortality , Preoperative Care/methods
6.
Int J Cardiol ; 184: 56-61, 2015 Apr 01.
Article in English | MEDLINE | ID: mdl-25697871

ABSTRACT

BACKGROUND: The type of atrial fibrillation (AF) is the sole prognostic factor that affects the level of recommendation for catheter ablation in the current guidelines. Despite being recognized as a predictor of recurrence, relatively little emphasis is given to left atrium (LA) size. The aim of this study was to assess the relative importance of LA volume and type of AF as predictors of outcome after PVI. METHODS: We assessed 809 consecutive patients with symptomatic drug-refractory AF (584 male, mean age 57 ± 11 years) undergoing 905 percutaneous PVI procedures in two centers. LA volume was assessed by cardiac CT and/or electroanatomical mapping prior to AF ablation. The study endpoint was symptomatic and/or documented AF recurrence. RESULTS: The majority of patients (73.2%, n=592) had paroxysmal AF. The mean indexed LA volume was 55 ± 20 ml/m(2). During a follow-up of 2.4 ± 1.7 years, there were 280 recurrences. The relapse rate of patients with paroxysmal AF in the highest tertile of LA volume was higher than the relapse rate of patients with non-paroxysmal AF in the lowest tertile (20.0% vs. 10.9% per person-year, respectively, p=0.041). LA volume (HR 1.16 for each 10 ml/m(2), 95% CI 1.09-1.23, p<0.001), female gender (HR 1.55, 95% CI 1.19-2.03, p=0.001), and non-paroxysmal AF (HR 1.31, 95% CI 1.01-1.69, p=0.039) were the only independent predictors of AF recurrence. Split-sample cross-validation resampling confirmed LA volume as the strongest predictor of relapse after PVI. CONCLUSION: Left atrial volume seems to be more important than the type of atrial fibrillation in predicting the long-term success of pulmonary vein isolation.


Subject(s)
Atrial Fibrillation/diagnostic imaging , Atrial Fibrillation/surgery , Catheter Ablation/trends , Heart Atria/diagnostic imaging , Aged , Atrial Fibrillation/mortality , Catheter Ablation/mortality , Female , Follow-Up Studies , Heart Atria/surgery , Humans , Male , Middle Aged , Multidetector Computed Tomography/mortality , Multidetector Computed Tomography/trends , Organ Size , Predictive Value of Tests , Prospective Studies , Registries , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...